NCT03618758 - Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 24, 2018

Primary Completion Date

August 31, 2023

Study Completion Date

December 2, 2023

Conditions

Gastric Cancer Stage IVPeritoneal CarcinomatosisIntraperitoneal PaclitaxelmFOLFOX6

Interventions

DRUG

Paclitaxel

"Intraperitoneal application of Paclitaxel Phase 1: Dose determination of Paclitaxel (Recommended Dose) Starting from 40mg/m² upto 100mg/m² maximum~Phase 2: Intraperitoneal Paclitaxel with recommended dose"

DRUG

mFOLFOX6 regimen

Systemic mFOLFOX6: 5-FU(2400mg/m²), Oxaliplatin(100mg/m²), Leucovorin(100mg/m²)

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si